November 23, 2009
Life Sciences News @ Gowlings

  Use Twitter?    Follow Gowlings news on Twitter


Valeant may fall if new drug disappoints-Barron's
http://www.reuters.com/article/rbssHealthcareNews/idUSN223658020091122

Pfizer to pay $6.3 mln to patient in Prempro lawsuit
http://www.reuters.com/article/rbssHealthcareNews/idUSN2024658320091121

CHMP takes negative stance on Avastin for glioblastoma
http://www.pharmatimes.com/WorldNews/article.aspx?id=16950

Merck Serono to invest 150 million euros in Beijing
http://www.pharmatimes.com/WorldNews/article.aspx?id=16953

VCs are looking for great ideas: The trick is to be able to get them to look at the business plan
http://www.nationalpost.com/scripts/story.html?id=2255368

Scientists hail Hobbie-J as 'cleverest rat'
http://www.telegraph.co.uk/news/worldnews/northamerica/usa/6622409/Scientists-hail-Hobbie-J-as-cleverest-rat.html

Cephalon delays Ception deal after mixed drug data
http://www.reuters.com/article/rbssHealthcareNews/idUSN2320024420091123

Spectrum inks deal with Korea's Handok for cancer drug
http://www.reuters.com/article/rbssHealthcareNews/idUSBNG28453420091123

US FDA reviewing Abbott diet drug risks
http://www.reuters.com/article/rbssHealthcareNews/idUSN2024703020091121

US drugmakers’ fury over price probe demands
http://www.pharmatimes.com/WorldNews/article.aspx?id=16948

Global Study of Salmon from Dalhousie University, Ecotrust, and the Swedish Institute for Food and Biotechnology Shows: “Sustainable” Food Production Isn’t So Sustainable
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20091123005225&newsLang=en

Patient in 23-year 'coma' was conscious all along
http://www.ananova.com/News/story/sm_3573509.html


Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

If you wish to subscribe/unsubscribe to any Gowlings newsletter, please visit http://www.gowlings.com/e-form/subscribe.asp and complete our subscription form. By your use of this service you agree to the Terms and Conditions set out at http://www.gowlings.com/resources/newsletterList.asp?intNewsletterTypeId=99. If you do not agree with the Terms and Conditions, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

Montréal Ottawa Kanata Toronto Hamilton Waterloo Region Calgary Vancouver Moscow London